(Q33337860)

25 July 2017

1 reference

title

Cladribine in the treatment of chronic lymphocytic leukemia (English)

1 reference

chronic lymphocytic leukemia

25 July 2017

0 references

1 reference

1 reference

Robak T

1

1 reference

25 July 2017

1 February 2001

1 reference

25 July 2017

1 reference

25 July 2017

40

1 reference

25 July 2017

551-564

1 reference

25 July 2017

5-6

1 reference

Cladribine (2-chlorodeoxyadenosine)

25 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: Possible role of nucleoside kinase(s)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

On the bioavailability of 2-chloro-2'-deoxyadenosine (CdA). The influence of food and omeprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097654

10.3109/10428190109097654

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference

PubMed ID

11426528